中医治疗房性早搏的研究进展

Research Progress of Traditional Chinese Medicine in the Treatment of Atrial Premature Beats

摘要:

房性早搏可归属于中医学心悸、怔忡范畴，病因病机分为虚、实、虚实夹杂3类，现代医家进一步丰富其辨证体系。中医治疗房性早搏常采用汤剂（经典经方与现代自拟方）、中成药（稳心颗粒等常用药及医院自制剂）、外治疗法（针刺、穴位贴敷等） 单独或联合使用，均能有效改善患者临床症状、减少早搏发作，且不良反应较少，其中稳心颗粒获评相关证型A类药物。中医辨证论治为核心的内服外治多种疗法，可作为房性早搏临床管理的重要方案，提供多元诊疗思路。目前中医相关研究仍存在作用机制不明确、临床试验设计有缺陷、疗效评价体系不完善等问题，未来需深化理论研究、创新科研方法，完善中医诊疗体系，推动中医治疗房性早搏的规范化与高质量发展。

Abstract:

Abstract： Atrial premature beats （APBs） can be classified under the categories of palpitations and fearful throbbing in traditional Chinese medicine （TCM）. The etiology and pathogenesis are divided into three types： deficiency syndrome， excess syndrome， and deficiency interwoven with excess syndrome. Modern TCM practitioners have further refined the syndrome differentiation system. In TCM treatment of APBs，decoctions （classic formulas and modern self-prescribed formulas）， Chinese patent medicines （e. g.， Wenxin Granules and other commonly used medicines， as well as hospital preparations）， and external therapies （acupuncture， acupoint application， etc.） are often used alone or in combination. All these approaches can effectively improve clinical symptoms and reduce the frequency of APB episodes with few adverse reactions. Among them，Wenxin Granules have been rated as an A-class drug for the APBs-relevant syndrome type. Various internal and external TCM therapies centered on syndrome differentiation and treatment can serve as important options for the clinical management of APBs，providing diversified diagnostic and treatment strategies. However，current TCM research still has limitations，such as unclear mechanisms of action，defects in clinical trial design，and an imperfect efficacy evaluation system. Future efforts should be focused on deepening theoretical research，innovating scientific research methods，improving the TCM diagnostic and treatment system，and promoting the standardization and high-quality development of TCM treatment for APBs.